logo

For the Inventor, By the Inventor

San Francisco, CA, United States of America

Daniel Almonacid

USPTO Granted Patents = 89 

 

 

Average Co-Inventor Count = 3.6

ph-index = 9

Forward Citations = 288(Granted Patents)

Forward Citations (Not Self Cited) = 155(Dec 10, 2025)


Inventors with similar research interests:


Company Filing History:

goldMedal56 out of 59 
 
Ubiome, Inc.
 patents
silverMedal32 out of 36 
 
Psomagen, Inc.
 patents
bronzeMedal1 out of 832,891 
Other
 patents

Years Active: 2017-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Microbiome-Derived Diagnostics
Therapeutics
Single Molecule Sequencing
CRISPR-Based Library Preparation
Toll-Like Receptors
Microbial Pharmacogenomics
High-Throughput Particle Handling
Nucleic Acid Sequences
Mental Health Conditions
Endocrine System Conditions
Locomotor System Conditions
Cardiovascular Disease
89 patents (USPTO):Explore Patents
1. 12060599 - Method and system for microbiome-derived diagnostics and therapeutics for bacterial vaginosis (2024-08-13),
2. 11987841 - Single molecule sequencing and unique molecular identifiers to characterize nucleic acid sequences (2024-05-21),
3. 11931400 - Therapeutic and diagnostics compositions targeting toll-like receptors and methods thereof (2024-03-19),
4. 11783914 - Method and system for panel characterizations (2023-10-10),
5. 11773455 - Method and system for microbiome-derived diagnostics and therapeutics infectious disease and other health conditions associated with antibiotic usage (2023-10-03),
6. 11634703 - Method and system for high-throughput particle handling by use of magnetic fields and device (2023-04-25),
7. 11621055 - Microorganism-related significance index metrics (2023-04-04),
8. 11572555 - Method and system for CRISPR-based library preparation and sequencing (2023-02-07),
9. 11424006 - Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide (2022-08-23),
10. 11001900 - Method and system for characterization for female reproductive system-related conditions associated with microorganisms (2021-05-11),
11. 10902938 - Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions (2021-01-26),
12. 10803992 - Method and system for microbiome-derived diagnostics and therapeutics for mental health associated conditions (2020-10-13),
13. 10803991 - Method and system for microbiome-derived diagnostics and therapeutics (2020-10-13),
14. 10803147 - Method and system for microbiome-derived diagnostics and therapeutics for locomotor system conditions (2020-10-13),
15. 10796800 - Method and system for microbiome-derived diagnostics and therapeutics for mental health associated conditions (2020-10-06),

Title: The Innovative Journey of Daniel Almonacid

Introduction: Daniel Almonacid, a talented inventor based in San Francisco, CA, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Daniel Almonacid holds several patents in the field of artificial intelligence and renewable energy technologies, showcasing his commitment to creating sustainable solutions for the future.

Career Highlights: With a background in engineering and a passion for problem-solving, Daniel Almonacid has successfully brought several of his inventions from concept to market, revolutionizing industries along the way.

Collaborations: Throughout his career, Daniel Almonacid has collaborated with leading research institutions and tech companies to further develop his inventions, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Daniel Almonacid's dedication to innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and entrepreneurs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…